We rank companies based on fund manager, research analyst and news sentiment
ICUI stock icon

ICU Medical
ICUI

$96.38
0.64%
 

About: ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Employees: 14,000

0
Funds holding %
of 6,474 funds
0
Analysts bullish %
of 3 analysts
News positive %

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

79% more call options, than puts

Call options by funds: $3.62M | Put options by funds: $2.02M

51% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 37

40% more repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 62

9% more funds holding

Funds holding: 216 [Q3] → 235 (+19) [Q4]

2.24% less ownership

Funds ownership: 91.32% [Q3] → 89.08% (-2.24%) [Q4]

18% less capital invested

Capital invested by funds: $2.62B [Q3] → $2.14B (-$479M) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$110
14%
upside
Avg. target
$127
31%
upside
High target
$136
41%
upside

3 analyst ratings

positive
100%
neutral
0%
negative
0%
Keybanc
Brett Fishbin
41%upside
$136
Overweight
Maintained
28 Feb 2024
Keybanc
Brett Fishbin
39%upside
$134
Overweight
Initiated
6 Feb 2024
CL King
Kristen Stewart
14%upside
$110
Buy
Initiated
14 Dec 2023

Financial journalist opinion